Viewing Study NCT00470704


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-01-04 @ 7:08 PM
Study NCT ID: NCT00470704
Status: COMPLETED
Last Update Posted: 2024-12-19
First Post: 2007-05-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
Sponsor: Nancy Lin, MD
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-05-14
Start Date Type: ACTUAL
Primary Completion Date: 2013-11-30
Primary Completion Date Type: ACTUAL
Completion Date: 2024-08-20
Completion Date Type: ACTUAL
First Submit Date: 2007-05-07
First Submit QC Date: None
Study First Post Date: 2007-05-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2022-01-05
Results First Submit QC Date: None
Results First Post Date: 2022-03-15
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-12-04
Last Update Post Date: 2024-12-19
Last Update Post Date Type: ACTUAL